Close Menu

NEW YORK – Many diagnostics companies' stocks fell in March, continuing the slight decrease from February as the 360Dx Index was down almost 2 percent month over month.

Of the 31 companies in the Index, 11 firms saw their share prices increase last month led by Meridian Bioscience (+25 percent) and GenMark Diagnostics (+22 percent). Meanwhile, 20 companies' stock prices fell, led by Adaptive Biotechnologies (-29 percent), Burning Rock Biotech (-25 percent), Quidel (-22 percent), and Accelerate Diagnostics (-17 percent).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.